Pharmacists provide patient value in team-based care

With inhaler in hand, Dr. Cheng Yuet went over every detail to make sure the patient understood how the drug would control their COPD symptoms. Dr. Yuet is proving what a difference it makes when pharmacists are integrated into the health care team. As part of an innovative model being used at UNT Health Science Center, Dr. Yuet and three other pharmacists manage the care of patients with chronic diseases such as asthma, diabetes and hypertension.

"Our scope is pretty broad, which is unique in pharmacy," Dr. Yuet said. "As part of the health care team, our pharmacists can prescribe, change and refill medications; order laboratory tests; and schedule in-person or telephone visits for chronic disease state management."

Many patients are unfamiliar with seeing a pharmacist in this role, Dr. Yuet said.

"It is important for patients to have awareness of how a pharmacist could help them reach their treatment goals alongside their physician or advanced practice nursing providers," she said.

The model has been shown to improve outcomes for patients whose chronic diseases make care complex. Patients who are referred to pharmacist visits might take more than a dozen medications daily. Success has also been realized in terms of quality, collaboration and financial sustainability.

The Pharmacist-Led Chronic Care Management Services model being used at UNTHSC is featured in the September issue of the Annals of Family Medicine, said Dr. Yuet, the corresponding author of the article.

The approach also has won recognition from the Texas Society of Health-System Pharmacists, which presented the Innovative Collaborative Practice Award to the UNT Health Clinical Practice Group in April.

The service is believed to be the most expansive collaborative agreement in the state. The broad scope allows pharmacists to provide comprehensive medication management to virtually any patient in the practice independently.

Chronic diseases, like diabetes, pose a significant challenge for both the patient and the physician, said Randy Martin, PharmD, Associate Dean for Clinical Affairs and Associate Professor of Pharmacotherapy.

"Patients find themselves keeping track of multiple medications and seeing an array of providers," he said. "For physicians, there's a lot going on with these patients. ?This is where pharmacist-led chronic care management comes in."

As the medication expert, the pharmacist can streamline the patient's medication regimen, order labs, and provide important education on medications and lifestyle modifications.

Four pharmacists and 48 physicians work in collaboration to provide primary and specialty care at UNTHSC clinics.

The model demonstrates a revenue-generating, quality-focused approach that also helps to reduce costs at the institution, Dr. Yuet said. It was designed to generate revenue for the practice and offset the cost to incorporate a clinical pharmacist into the interprofessional health care team.

The approach benefits patients and health care.

"When we integrated pharmacists into the practice two years ago, we were passionate about giving patients access to a pharmacist in the clinic in a sustainable way," Dr. Martin said. "Chronic care management enhances patients' access to health care in a way that is complementary to their in-clinic visits."

Wei C Yuet, Jessica Gardea, Didi Ebert, Randy D Martin.
Pharmacist-Led Chronic Care Management Services.
Ann Fam Med September/October 2019 vol. 17 no. 5 465. doi: 10.1370/afm.2440.

Most Popular Now

Novartis announces plan to initiate clinical trial…

Novartis today announced plans to initiate a Phase III clinical trial to study canakinumab in patients with COVID-19 pneumonia. The CAN-COVID trial will examine the effic...

Gilead announces results from Phase 3 trial of inv…

Gilead Sciences, Inc. (Nasdaq: GILD) announced topline results from the open-label, Phase 3 SIMPLE trial evaluating 5-day and 10-day dosing durations of the investigation...

AstraZeneca and Oxford University announce landmar…

AstraZeneca and the University of Oxford announced an agreement for the global development and distribution of the University’s potential recombinant adenovirus vaccine a...

Sanofi and Regeneron provide update on U.S. Phase …

Sanofi and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced the preliminary results from the Phase 2 portion of an ongoing Phase 2/3 trial evaluating Kevzar...

Roche's COVID-19 antibody test receives FDA Emerge…

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that the U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) (1) for its new Elecsys® Ant...

Pfizer and BioNTech dose first participants in the…

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced that the first participants have been dosed in the U.S. in the Phase 1/2 clinical trial for the BNT162 va...

Arthritis drug may improve respiratory function in…

A small study in Greece found that the clinically approved anti-inflammatory drug anakinra, used to treat rheumatoid arthritis, improved respiratory function in patients ...

Early indicators of vaccine efficacy

Ludwig-Maximilians-Universität (LMU) in Munich researchers have shown that a specific class of immune cells in the blood induced by vaccination is an earlier indicator of...

Frankfurt researchers discover potential targets f…

A team of biochemists and virologists at Goethe University and the Frankfurt University Hospital were able to observe how human cells change upon infection with SARS-CoV-...

Vitamin D linked to low virus death rate

A new study has found an association between low average levels of vitamin D and high numbers of COVID-19 cases and mortality rates across 20 European countries. The r...

Loss of smell associated with milder clinical cour…

Following an earlier study that validated the loss of smell and taste as indicators of SARS-CoV-2 infection, researchers at UC San Diego Health report in newly published ...

Can an existing HIV medication slow the spread of …

A team of scientists from St. Michael's Hospital, Sinai Health and Sunnybrook Health Sciences Centre have launched a clinical trial to understand whether an existing drug...